glp 1 agonist therapy Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Struggling with GLP-1 therapy side
Description
Its shorter duration of action produces pronounced effects on postprandial glucose through delayed gastric emptying
Early on Holst found that the L-cells produced a peptide which contained the full glucagon sequence extended in both ends of the molecule
Bethel MA, Patel RA, Merrill P, Lokhnygina Y, Buse JB, Mentz RJ, et al
Choi, I
7 As practitioners, the slowed gastric emptying effect raises concern for co-administered drug absorption
but can be obtained by a physician for patients with refractory gastroparesis though the Investigational New Drug (IND) application program at the FDA
